These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 12899670)
1. Gastrointestinal and systemic uptake of bismuth in mice after oral exposure. Larsen A; Martiny N; Stoltenberg M; Danscher G; Rungby J Pharmacol Toxicol; 2003 Aug; 93(2):82-90. PubMed ID: 12899670 [TBL] [Abstract][Full Text] [Related]
2. Distribution of bismuth in the rat after oral dosing with ranitidine bismuth citrate and bismuth subcitrate. Canena J; Reis J; Pinto AS; Santos AM; Leitão J; Pinheiro T; Quina MG J Pharm Pharmacol; 1998 Mar; 50(3):279-83. PubMed ID: 9600719 [TBL] [Abstract][Full Text] [Related]
3. Seven-day is more effective than 4-day ranitidine bismuth citrate-based triple therapy in eradication of Helicobacter pylori in children: a prospective randomized study. Tam YH; Yeung CK; Lee KH Aliment Pharmacol Ther; 2006 Jul; 24(1):81-6. PubMed ID: 16803605 [TBL] [Abstract][Full Text] [Related]
4. Histochemical tracing of bismuth in Helicobacter pylori after in vitro exposure to bismuth citrate. Stoltenberg M; Martiny M; Sørensen K; Rungby J; Krogfelt KA Scand J Gastroenterol; 2001 Feb; 36(2):144-8. PubMed ID: 11252405 [TBL] [Abstract][Full Text] [Related]
5. In vivo distribution of bismuth in the mouse brain: influence of long-term survival and intracranial placement on the uptake and transport of bismuth in neuronal tissue. Larsen A; Stoltenberg M; Søndergaard C; Bruhn M; Danscher G Basic Clin Pharmacol Toxicol; 2005 Sep; 97(3):188-96. PubMed ID: 16128915 [TBL] [Abstract][Full Text] [Related]
6. The efficacy of ranitidine bismuth citrate, amoxicillin and doxycycline or tetracycline regimens as a first line treatment for Helicobacter pylori eradication. Akyildiz M; Akay S; Musoglu A; Tuncyurek M; Aydin A Eur J Intern Med; 2009 Jan; 20(1):53-7. PubMed ID: 19237093 [TBL] [Abstract][Full Text] [Related]
7. Levofloxacin- vs. ranitidine bismuth citrate-containing therapy after H. pylori treatment failure. Gisbert JP; Gisbert JL; Marcos S; Moreno-Otero R; Pajares JM Helicobacter; 2007 Feb; 12(1):68-73. PubMed ID: 17241304 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of bismuth and ranitidine following single doses of ranitidine bismuth citrate. Koch KM; Davis IM; Gooding AE; Yin Y Br J Clin Pharmacol; 1996 Aug; 42(2):201-5. PubMed ID: 8864318 [TBL] [Abstract][Full Text] [Related]
10. Comparison of ranitidine bismuth citrate, tetracycline and metronidazole with ranitidine bismuth citrate and azithromycin for the eradication of Helicobacter pylori in patients resistant to PPI based triple therapy. Altintaş E; Ulu O; Sezgin O; Aydin O; Camdeviren H Turk J Gastroenterol; 2004 Jun; 15(2):90-3. PubMed ID: 15334317 [TBL] [Abstract][Full Text] [Related]
11. Citrate enhances the protective effect of orally administered bismuth subnitrate against the nephrotoxicity of cis-diamminedichloroplatinum. Kondo Y; Himeno S; Satoh M; Naganuma A; Nishimura T; Imura N Cancer Chemother Pharmacol; 2004 Jan; 53(1):33-8. PubMed ID: 14530870 [TBL] [Abstract][Full Text] [Related]
12. [Effect of meals on resorption of bismuth from an oral bismuth gallate/bismuth nitrate preparation]. Leonhardt H; Klotz U Med Klin (Munich); 1991 Apr; 86(4):194-7. PubMed ID: 2056984 [TBL] [Abstract][Full Text] [Related]
13. The efficacy of two-week therapy with ranitidine bismuth citrate, amoxicillin and clarithromycin on Helicobacter pylori eradication in clarithromycinresistant and- sensitive cases. Aydin A; Onder GF; Akarca US; Tekin F; Tunçyürek M; Musoğlu A Turk J Gastroenterol; 2005 Dec; 16(4):203-6. PubMed ID: 16547848 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of bismuth and ranitidine following multiple doses of ranitidine bismuth citrate. Koch KM; Kerr BM; Gooding AE; Davis IM Br J Clin Pharmacol; 1996 Aug; 42(2):207-11. PubMed ID: 8864319 [TBL] [Abstract][Full Text] [Related]
15. Bismuth-induced lysosomal rupture in J774 cells. Stoltenberg M; Larsen A; Zhao M; Danscher G; Brunk UT APMIS; 2002 May; 110(5):396-402. PubMed ID: 12076257 [TBL] [Abstract][Full Text] [Related]
16. A study relating to bioavailability and renal elimination of bismuth after oral administration of basic bismuth nitrate. Behrendt WA; Gröger C; Kuhn D; Schulz HU; Topfmeier P Int J Clin Pharmacol Ther Toxicol; 1991 Sep; 29(9):357-60. PubMed ID: 1937997 [TBL] [Abstract][Full Text] [Related]
17. Mercury species in lymphoid and non-lymphoid tissues after exposure to methyl mercury: correlation with autoimmune parameters during and after treatment in susceptible mice. Havarinasab S; Björn E; Nielsen JB; Hultman P Toxicol Appl Pharmacol; 2007 May; 221(1):21-8. PubMed ID: 17399758 [TBL] [Abstract][Full Text] [Related]
18. Tissue uptake of bismuth from shotgun pellets. Pamphlett R; Danscher G; Rungby J; Stoltenberg M Environ Res; 2000 Mar; 82(3):258-62. PubMed ID: 10702334 [TBL] [Abstract][Full Text] [Related]
19. Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients. Köksal AS; Parlak E; Filik L; Yolcu OF; Odemiş B; Ulker A; Saşmaz N; Ozden A; Sahin B J Gastroenterol Hepatol; 2005 Apr; 20(4):637-42. PubMed ID: 15836716 [TBL] [Abstract][Full Text] [Related]
20. Uptake of ingested bovine lactoferrin and its accumulation in adult mouse tissues. Fischer R; Debbabi H; Blais A; Dubarry M; Rautureau M; Boyaka PN; Tome D Int Immunopharmacol; 2007 Oct; 7(10):1387-93. PubMed ID: 17673154 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]